SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053604
Filing Date
2020-11-12
Accepted
2020-11-12 16:28:07
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-10q_20200930.htm 10-Q 2957259
2 EX-31.1 cccc-ex311_9.htm EX-31.1 18761
3 EX-31.2 cccc-ex312_8.htm EX-31.2 18761
4 EX-32.1 cccc-ex321_6.htm EX-32.1 9176
5 EX-32.2 cccc-ex322_7.htm EX-32.2 9061
  Complete submission text file 0001564590-20-053604.txt   9014719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cccc-20200930.xml EX-101.INS 1728598
7 XBRL TAXONOMY EXTENSION SCHEMA cccc-20200930.xsd EX-101.SCH 67284
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cccc-20200930_cal.xml EX-101.CAL 53018
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cccc-20200930_def.xml EX-101.DEF 237351
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20200930_lab.xml EX-101.LAB 492454
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20200930_pre.xml EX-101.PRE 377257
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 201307156
SIC: 2836 Biological Products, (No Diagnostic Substances)